|
23 Feb 2007 |
Hollis-Eden Pharmaceuticals Presents Additional Positive Data with Novel Steroid Hormone in Models of Prostate and Breast Cancer
|
|
23 Feb 2007 |
Valeant Pharmaceuticals Files Investigational New Drug Application for Cesamet(R) in Cancer Chemotherapy-Induced Neuropathic Pain
|
|
23 Feb 2007 |
Auris Medical initiating phase I/II clinical trial with AM-101
|
|
22 Feb 2007 |
Pharmacyclics Receives Refuse to File Letter for Xcytrin
|
|
22 Feb 2007 |
Manhattan Pharmaceuticals, Inc. Completes Enrollment In Phase 2a Study Of Oral Oleoyl-estrone For Obesity
|
|
22 Feb 2007 |
Sosei Announces Progression of SD118 Towards Phase 1 Studies
|
|
22 Feb 2007 |
Allegiance Equity Corporation Announces Positive Results of In Vitro Studies and an Open Label Trial for Relieva(R) in Treating Atopic Dermatitis
|
|
22 Feb 2007 |
Landark study shows important benefits of Seretide(TM) mtreatment for patients with fatal lung disease, COPD
|
|
21 Feb 2007 |
BioMarin Announces Results From Phase 2 Clinical Study of 6R-BH4 in Poorly Controlled Hypertension
|
|
21 Feb 2007 |
Lux Biosciences Initiates LUMINATE Pivotal Clinical Trials of Its Next-Generation Calcineurin Inhibitor, LX211, in Uveitis
|
|
21 Feb 2007 |
Roche and GSK agree on two transactions
|
|
21 Feb 2007 |
Avalon Pharmaceuticals Announces the Initiation of Drug Discovery Program for the MYC Oncoprotein - One of the Most Important and Intractable Cancer Targets
|
|
21 Feb 2007 |
Alteon's Investigational Drug Alagebrium Demonstrates Ability to Improve Functional Membrane Transport in a Rat Model of Chronic Peritoneal Dialysis, Indicating a Potential Role in Kidney Disease
|
|
21 Feb 2007 |
Novacea's ASCENT Phase 2 Trial Published in the Journal of Clinical Oncology
|
|
21 Feb 2007 |
Theravance Announces FDA Acceptance of Telavancin NDA
|
|
21 Feb 2007 |
Hana Biosciences Reports Likely Delay in Launch of Zensana
|
|
20 Feb 2007 |
Basilea Reports Positive Phase III Results for Alitretinoin
|
|
20 Feb 2007 |
CeNeS Pharmaceuticals plc: Successful Phase III results announced on Lead Product M6G
|
|
20 Feb 2007 |
Cardiome and Astellas Announce Acceptance of NDA for Review
|
|
17 Feb 2007 |
GPC Biotech Submits NDA for Lead Oncology Drug Candidate Satraplatin
|
|
17 Feb 2007 |
Anti-HIV Medication PREZISTA(TM) Receives Conditional Marketing Authorization in the European Union
|
|
17 Feb 2007 |
Positive outcome from pre-Phase III FDA and EMEA scientific advice meetings for VitorTM
|
|
17 Feb 2007 |
Roche files application in Europe for Tamiflu 30 and 45 mg capsules
|
|
17 Feb 2007 |
InSite Vision Announces License Agreement With Inspire Pharmaceuticals
|
|
17 Feb 2007 |
Gilead's New Drug Application for Ambrisentan Receives Priority Review Status
|
